Does TNXP pay dividends?

Tonix Pharmaceuticals Holding Corp (TNXP) does not currently pay a regular dividend.

What is TNXP's market cap?

Tonix Pharmaceuticals Holding Corp (TNXP) has a market capitalization of $241.83M with a current stock price of $14.10.

Tonix Pharmaceuticals Holding Corp (TNXP)

Official site

HEALTHCARE • BIOTECHNOLOGY • NASDAQ

$14.10

+0.51 (+3.75%)

Market Cap: $241.83M

Last updated: Sep 01, 2026 at 5:00 PM ET

Earnings

Performance (10Y)

Beat Rate

70%(28/40)

Avg Surprise

-1.84%

Streak

1 Q

Upcoming Estimates

Period ending Sep 30, 2026

EPS Consensus$-2.51

Range$-2.51 - $-2.51

1 analysts

EPS RevisionsNo revisions (7d)

30d

EPS Estimate Drift

90d ago$-2.53-0.8%

60d ago$-2.41+4.0%

30d ago$-2.41+4.0%

7d ago$-2.41+4.0%

Current$-2.51

Revenue Consensus

$12M

Range$8M - $19M

4 analysts

Period ending Dec 31, 2026

EPS Consensus$-2.28

Range$-2.73 - $-1.83

2 analysts

Revenue Consensus

$29M

Range$24M - $38M

3 analysts

Period	Reported	Est.	Range	Surprise	B/M	Analysts	Revisions	YoY
Dec 31, 2026Dec 26EST	-	$-2.28	$-2.73 - $-1.83	-	-	2	-	-
Sep 30, 2026Sep 26EST	-	$-2.51	$-2.51 - $-2.51	-	-	1	0 1 30d	-
Jun 30, 2026Jun 26 Reported Aug 10, 2026Reported Aug 10	$-2.44	$-2.71	$-2.76 - $-2.48	+9.96%	Beat	2	0 1 30d	+39.0%
Mar 31, 2026Mar 26 Reported May 11, 2026Reported May 11	$-2.93	$-2.54	$-2.98 - $-2.10	-15.35%	Miss	2	0 1 30d	-11.0%
Dec 31, 2025Dec 25 Reported Mar 12, 2026Reported Mar 12	$-3.98	$-3.19	$-3.19 - $-3.19	-24.82%	Miss	1	1 0 30d	+59.2%
Sep 30, 2025Sep 25 Reported Nov 10, 2025Reported Nov 10	$-3.70	$-2.75	$-2.75 - $-2.75	-34.55%	Miss	1	1 0 30d	+85.5%
Jun 30, 2025Jun 25 Reported Aug 11, 2025Reported Aug 11	$-4.00	$-1.88	$-1.88 - $-1.88	-112.77%	Miss	1	1 0 30d	+99.1%
Mar 31, 2025Mar 25 Reported May 12, 2025Reported May 12	$-2.64	$-3.09	$-3.09 - $-3.09	+14.56%	Beat	1	1 0 30d	+99.5%
Dec 31, 2024Dec 24 Reported Mar 18, 2025Reported Mar 18	$-9.77	$-3.91	$-3.91 - $-3.91	-149.80%	Miss	0	No revisions (30d)	-1035.7%
Sep 30, 2024Sep 24 Reported Nov 12, 2024Reported Nov 12	$-25.56	N/A	-	+96.53%	Beat	3	No revisions (30d)	+99.6%
Jun 30, 2024Jun 24 Reported Aug 16, 2024Reported Aug 16	$-464.22	$-720.00	$-724.09 - $-717.91	+35.52%	Beat	3	1 0 30d	+94.6%
Mar 31, 2024Mar 24 Reported Apr 1, 2024Reported Apr 1	$-576.00	$-1136.00	$-1136.08 - $-1135.92	+49.30%	Beat	2	No revisions (30d)	+94.5%
Dec 31, 2023Dec 23 Reported Mar 25, 2024Reported Mar 25	$-0.86	$-1.64	$-1.83 - $-1.46	+47.56%	Beat	3	No revisions (30d)	-53.6%
Sep 30, 2023Sep 23 Reported Nov 9, 2023Reported Nov 9	$-5856.00	$-4496.00	$-4496.17 - $-4495.68	-30.25%	Miss	3	1 0 30d	+57.6%
Jun 30, 2023Jun 23 Reported Aug 10, 2023Reported Aug 10	$-8576.00	$-5264.00	$-5264.03 - $-5263.98	-62.92%	Miss	2	1 0 30d	+64.9%
Mar 31, 2023Mar 23 Reported May 8, 2023Reported May 8	$-10400.00	$-11400.00	$-11400.09 - $-11399.92	+8.77%	Beat	2	No revisions (30d)	+67.5%
Dec 31, 2022Dec 22 Reported Mar 13, 2023Reported Mar 13	$-0.56	$-0.86	$-1.41 - $-0.54	+34.88%	Beat	3	No revisions (30d)	+75.0%
Sep 30, 2022Sep 22 Reported Nov 7, 2022Reported Nov 7	$-13800.00	$-26400.00	$-26400.30 - $-26399.70	+47.73%	Beat	2	No revisions (30d)	+56.9%
Jun 30, 2022Jun 22 Reported Aug 8, 2022Reported Aug 8	$-24400.00	$-28600.00	$-28600.00 - $-28600.00	+14.69%	Beat	0	No revisions (30d)	+45.5%
Mar 31, 2022Mar 22 Reported May 9, 2022Reported May 9	$-32000.00	$-32000.00	$-32000.00 - $-31999.99	+0.00%	Beat	3	No revisions (30d)	+28.6%
Dec 31, 2021Dec 21 Reported Mar 14, 2022Reported Mar 14	$-2.24	$-1.92	$-1.93 - $-1.91	-16.67%	Miss	2	No revisions (30d)	+30.0%
Sep 30, 2021Sep 21 Reported Nov 8, 2021Reported Nov 8	$-32000.00	$-44800.00	$-44800.00 - $-44800.00	+28.57%	Beat	2	No revisions (30d)	+44.4%
Jun 30, 2021Jun 21 Reported Aug 9, 2021Reported Aug 9	$-44800.00	$-38400.00	$-38400.01 - $-38400.00	-16.67%	Miss	2	No revisions (30d)	+69.6%
Mar 31, 2021Mar 21 Reported May 10, 2021Reported May 10	$-44800.00	$-38400.00	$-38400.01 - $-38400.00	-16.67%	Miss	2	No revisions (30d)	-466566.7%
Dec 31, 2020Dec 20 Reported Mar 15, 2021Reported Mar 15	$-3.20	$-2.40	$-2.41 - $-2.40	-33.33%	Miss	2	1 0 30d	+100.0%
Sep 30, 2020Sep 20 Reported Nov 9, 2020Reported Nov 9	$-57600.00	$-70400.00	$-70400.00 - $-70400.00	+18.18%	Beat	2	No revisions (30d)	+94.2%
Jun 30, 2020Jun 20 Reported Aug 10, 2020Reported Aug 10	$-147200.00	$-134400.00	$-134400.02 - $-134399.99	-9.52%	Beat	2	No revisions (30d)	+85.3%
Mar 31, 2020Mar 20 Reported May 12, 2020Reported May 12	$-9.60	$-10.08	$-10.19 - $-9.98	+4.76%	Beat	2	No revisions (30d)	+100.0%
Dec 31, 2019Dec 19 Reported Mar 24, 2020Reported Mar 24	$-1000000.00	$-953600.00	$-953600.26 - $-953599.74	-4.87%	Beat	2	No revisions (30d)	-51129.5%
Sep 30, 2019Sep 19 Reported Nov 8, 2019Reported Nov 8	$-1000000.00	$-1000000.00	$-1000000.45 - $-999999.55	+0.00%	Beat	2	No revisions (30d)	+0.0%
Jun 30, 2019Jun 19 Reported Aug 12, 2019Reported Aug 12	$-1000000.00	$-1000000.00	$-1000000.05 - $-999999.95	+0.00%	Beat	3	No revisions (30d)	+0.0%
Mar 31, 2019Mar 19 Reported May 13, 2019Reported May 13	$-1000000.00	$-1000000.00	$-1000000.08 - $-999999.92	+0.00%	Beat	2	No revisions (30d)	+0.0%
Dec 31, 2018Dec 18 Reported Mar 18, 2019Reported Mar 18	$-1952.00	$-1172.27	$-1172.51 - $-1171.86	-66.51%	Miss	3	1 0 30d	+10.3%
Sep 30, 2018Sep 18 Reported Nov 9, 2018Reported Nov 9	$-1000000.00	$-1000000.00	$-1000000.00 - $-1000000.00	+0.00%	Beat	0	No revisions (30d)	+0.0%
Jun 30, 2018Jun 18 Reported Aug 13, 2018Reported Aug 13	$-1000000.00	$-1000000.00	$-1000000.09 - $-999999.86	+0.00%	Beat	4	No revisions (30d)	+0.0%
Mar 31, 2018Mar 18 Reported May 14, 2018Reported May 14	$-1000000.00	$-1000000.00	$-1000000.00 - $-1000000.00	+0.00%	Beat	1	No revisions (30d)	+0.0%
Dec 31, 2017Dec 17 Reported Mar 12, 2018Reported Mar 12	$-2176.00	$-2480.00	$-2480.02 - $-2479.97	+12.26%	Beat	2	No revisions (30d)	-73166.0%
Sep 30, 2017Sep 17 Reported Nov 7, 2017Reported Nov 7	$-1000000.00	$-1000000.00	-	+0.00%	Beat	-	-	+0.0%
Jun 30, 2017Jun 17 Reported Aug 14, 2017Reported Aug 14	$-1000000.00	$-1000000.00	-	+0.00%	Beat	-	-	-
Mar 31, 2017Mar 17 Reported Apr 17, 2017Reported Apr 17	$-1000000.00	$-1000000.00	-	+0.00%	Beat	-	-	-
Dec 31, 2016Dec 16 Reported Mar 3, 2017Reported Mar 3	$-2.97	N/A	-	+97.72%	Beat	-	-	-
Sep 30, 2016Sep 16 Reported Nov 10, 2016Reported Nov 10	$-1000000.00	$-1000000.00	-	+0.00%	Beat	-	-	-

Key Metrics

Valuation
P/E Ratio	-1.08	EV/EBITDA	0.94x
Price/FCF	-1.48x	FCF Yield	-67.41%
Profitability
Profit Margin	0.00%	Operating Margin	-314.00%
ROE	-81.80%	ROIC	N/A
Financial Health
Debt/Equity	N/A	Interest Coverage	N/A
Current Ratio	6.61x	Quick Ratio	6.46x
Trading Statistics
Beta	1.69	Avg Volume	493.91K
52-Week High	$31.55	52-Week Low	$9.40

Technical Indicators Dashboard

Moving Averages

SMA 10$13.13

SMA 20$12.61

SMA 50$12.01

SMA 200$14.17

EMA 10$13.24

EMA 20$12.72

EMA 50$12.31

EMA 200$14.77

MACD

Line: 0.58Signal: 0.42Hist: 0.16

ADX

ADX: 32.1+DI: 25.4-DI: 9.4

Aroon & PSAR

Aroon Up100.0

Aroon Down12.0

PSAR$12.55

Bollinger Bands

Upper Band$14.19

Lower Band$11.03

%B Position2509%(Upper)

Band Width0.97

RSI (14-Day)

Neutral

68.6

Momentum Oscillators

Stoch %K82.9

Stoch %D84.8

Williams %R-14.8

ROC (10d)11.4%

Momentum1.44

CCI (20d)166.0

MFI (14d)71.9

Volatility Measures

ATR (14d)$0.84(6.0%)

StdDev (20d)0.79

Hist Vol49.2%(High)

Volume Flow

VWAP$13.98

OBV-7.3M

AD Line-31.9M

CMF (20d)0.080

Volume Metrics

Avg Vol (20d)501.2K

Vol Ratio1.1x

VWMA (20d)$12.78

Pivot Points

R3$14.63

R2$14.31

R1$13.95

Pivot Point$13.62

S1$13.26

S2$12.94

S3$12.58

Advanced Oscillators

TSI23.01

Ultimate Osc55.9

KST157.18

Financial Data

Quarter	Jun 2026	Mar 2026	Dec 2025	Sep 2025	Jun 2025	Mar 2025	Dec 2024	Sep 2024	Jun 2024	Mar 2024	Dec 2023	Sep 2023
Total Revenue	$13.54M	$6.88M	$5.39M	$3.29M	$2.00M	$2.43M	$2.58M	$2.82M	$2.21M	$2.48M	$3.78M	$3.99M
Cost of Revenue	$703,000	$1.58M	$1.06M	$1.37M	$3.27M	$943,000	$1.18M	$1.55M	$3.37M	$1.66M	$2.37M	$2.37M
Gross Profit	$12.84M	$5.30M	$4.33M	$1.92M	$-1,274,000	$1.49M	$1.40M	$1.27M	$-1,159,000	$822,000	$1.41M	$1.61M

Operating Expenses	$55.38M	$46.84M	$52.62M	$34.99M	$27.02M	$17.54M	$23.88M	$16.82M	$76.16M	$22.17M	$28.74M	$29.76M
R&D	$19.42M	$18.21M	$16.94M	$9.29M	$10.82M	$7.44M	$8.30M	$9.11M	$9.70M	$12.86M	$17.12M	$21.05M
SG&A	$35.96M	$28.62M	$35.68M	$25.70M	$16.20M	$10.10M	$15.58M	$7.71M	$7.50M	$9.31M	$11.62M	$8.71M
Operating Income	$-42,535,000	$-41,537,000	$-48,286,000	$-33,067,000	$-28,296,000	$-16,054,000	$-22,480,000	$-15,554,000	$-77,316,000	$-21,351,000	$-27,329,000	$-28,147,000

Interest Income	$1.43M	$1.35M	$0	$1.23M	$943,000	$394,000	$0	$18,000	$1,000	$0	$0	$0
Interest Expense	$0	$0	$89,000	$0	$0	$2.09M	$933,000	$301,000	$0	$0	$0	$0
Income Before Tax	$-41,152,000	$-40,194,000	$-46,981,000	$-32,992,000	$-29,308,000	$-17,752,000	$-23,034,000	$-15,881,000	$-78,776,000	$-14,939,000	$-25,607,000	$-28,147,000
Income Tax Expense	$-600,000	$0	$-71,000	$-982,000	$-1,036,000	$-923,000	$-926,000	$-1,668,000	$0	$0	$0	$0

Net Income	$-40,552,000	$-40,194,000	$-46,910,000	$-32,010,000	$-28,272,000	$-16,829,000	$-22,108,000	$-14,213,000	$-78,776,000	$-14,939,000	$-27,322,000	$-27,975,000

EBITDA	$-41,965,000	$-40,985,000	$-48,376,000	$-33,762,000	$-27,931,000	$-15,496,000	$-21,408,000	$-14,879,000	$-77,443,000	$-13,427,000	$-24,346,000	$-26,931,000
EBIT	$-42,584,000	$-41,540,000	$-48,864,000	$-34,223,000	$-30,251,000	$-16,054,000	$-22,104,000	$-15,598,000	$-78,777,000	$-14,939,000	$-25,607,000	$-28,147,000

* Some calculated fields are derived from available data when not provided by source

Related GNG Research

No research available

Be the first to write about TNXP

News

Tonix Pharmaceuticals (NASDAQ:TNXP) CEO Buys $27,580.00 in Stock

Tonix Pharmaceuticals (NASDAQ:TNXP) CEO Seth Lederman purchased 2,000 shares of the company's stock for $27,580, increasing his direct ownership to 11,005 shares. The company recently reported quarterly revenue of $13.54 million and an adjusted loss of $2.44 per share, surpassing analyst expectations despite remaining unprofitable. Analysts maintain a "Buy" rating for TNXP, with an average target price of $24.50.

MarketBeat•Aug 31, 2026 11:43 PM8/31/26•

Somewhat-Bullish

Tonix Pharmaceuticals director bagger buys $12,600 in stock

Richard H. Bagger, a director at Tonix Pharmaceuticals Holding Corp. (NASDAQ:TNXP), recently purchased 1,000 shares of the company's common stock for a total of $12,600. This insider transaction occurred on August 20, 2026, at $12.60 per share, bringing his direct holdings to 1,000 shares. The purchase follows strong Q2 results where the company beat analyst expectations for earnings and revenue, largely driven by sales of its product Tonmya.

Investing.com•Aug 24, 2026 2:12 PM8/24/26•

Somewhat-Bullish

Tonix Pharmaceuticals director bagger buys $12,600 in stock

Richard H. Bagger, a director at Tonix Pharmaceuticals Holding Corp. (NASDAQ:TNXP), recently purchased 1,000 shares of the company's common stock for $12,600. This insider acquisition follows strong Q2 results where Tonix Pharmaceuticals exceeded analyst expectations in earnings and revenue, primarily driven by sales of Tonmya. Despite a raised price target from Raymond James, concerns persist regarding the company's ongoing losses and limited cash runway.

Investing.com•Aug 24, 2026 12:46 PM8/24/26•

Bullish

Tonix Pharmaceuticals (TNXP) director buys 1,000 company shares

Richard H. Bagger, a director at Tonix Pharmaceuticals Holding Corp. (TNXP), purchased 1,000 shares of common stock on August 20, 2026, at a price of $12.60 per share. Following this transaction, Bagger directly holds 1,000 shares of the company's common stock. This insider trading activity was reported via a Form 4 filing with the SEC.

Stock Titan•Aug 24, 2026 12:46 PM8/24/26•

Somewhat-Bullish

Insider Buying: Tonix Pharmaceuticals (NASDAQ:TNXP) Director Purchases $12,600.00 in Stock

Tonix Pharmaceuticals Director Richard Bagger recently purchased 1,000 shares of the company's stock for $12,600. The transaction increased his direct holdings in the company to 1,000 shares. Despite the insider buying and a "Buy" consensus rating from analysts, Tonix Pharmaceuticals remains deeply unprofitable, with a negative net margin of 548.64%.

MarketBeat•Aug 24, 2026 12:46 PM8/24/26•

Somewhat-Bullish

Frequently Asked Questions About TNXP

Does TNXP pay dividends?: Tonix Pharmaceuticals Holding Corp (TNXP) does not currently pay a regular dividend.
What is TNXP's market cap?: Tonix Pharmaceuticals Holding Corp (TNXP) has a market capitalization of $241.83M with a current stock price of $14.10.

Get full access to GNG Research

Create a free account to access portfolio tracking, advanced tools, and more.

Create Free Account Log In